"Intimate Enemies" scene, where Old Xu and someone played hide-and-seek in Sanlitun, suddenly fountains surrounded them, then they did what they had to do in this scene. For those colleagues who often work overtime and stay up late, this scene is quite disillusioning. Xu's entertainment features are familiar, but the text and theatrical potential of "Du Lala" aren't supported by such familiarity, especially in an era full of Hollywood career films. So when "Intimate Enemies" starts by introducing what 'lithium' is, your attention perks up immediately; it seems that Xu has found her material and insight in commercial films. One advantage Xu has is that she doesn't mind whether style is really needed to judge the film's quality. You see, art-house directors turning to commercial films always hold back a bit creatively, let alone emotional female directors. Not long ago, Ma Liwen's exploration of comedy methods was overly narrow (heavily relying on dialects and flash). Although professional terms related to investment banking once filled the screen throughout the movie, fortunately, they were explained briskly and simply, just like attending a basic course. From the moment () and Xing meet each other in the film, the complex commercial battles on stage and the emotional tussles under the table intertwine closely. Xu Jinglei and Xing exchange moves, which is not only a realistic portrayal of investment bankers' experiences but also a review and new engagement of their characters' emotional hues. They were once lovers, with lingering ties emotionally, and these designs, though not entirely novel, maintain a layered rhythm that enhances the viewing experience. Just take the "Mole" battle in the movie as an example (the filming team of () provided great help in shooting), when Xing comes to the enemy company's spy residence, the door opens, and his ex-lover is already sitting inside. Thereafter, Xu Jinglei returns home to visit her father, and as soon as she arrives at the courtyard, she sees Xing playing the piano and singing happily with her niece. The previously cold and indifferent Xu Jinglei towards workplace life begins to handle her job competently, while the clueless Xing about women's hearts also integrates into the emotional system. Because this symmetrical dramatic design is all brilliant segments, compared to "Du Lala", the way of storytelling here is much more skillful. Ultimately, the performance of the actors determines the play. In "Du Lala", the interaction between Xing and Xu Jinglei had certain limitations because the male character was too flat. However, in this film, he stands on the opposite side of the "prequel", being low in EQ, childish, even a bit foolishly wise, which gives an arc to Xing's sly smile and adds a touch of friendliness. In classic Hollywood romantic comedies, whether the bickering couple works often depends on whether the characters are likable. Therefore, when they start opening up about their love for each other, we give emotional recognition in real-time while watching. As for the other beautiful scenery and beauties in this film, they are common configurations in this type of movie we usually see, providing a definitely comfortable viewing sensation. Since the decline in mid-November 2011, the pharmaceutical industry has been one of the leading industries in terms of decline across all sectors, failing to show good defensive characteristics during market downturns. In January 2012, the pharmaceutical industry even submitted its "first place in declines" report card. The research department released its February investment strategy, considering the pharmaceutical industry from both fundamental and valuation perspectives, pointing out that after experiencing a significant drop in the 2011 market downturn, there may now be a rebound demand. Analyzing from the fundamental perspective, in the short term, the decline in Chinese herbal medicine prices, the decrease in chemical raw materials in 2011 and its aftermath will no longer exist in 2012, and it is expected that the industry's profit growth rate will gradually recover. In the long term, aging, changes in disease patterns, and new technologies and drugs are the driving forces behind the long-term growth of the pharmaceutical industry. Analyzing from the industry valuation perspective (as of January 19th this year), the price-earnings ratios (P/E) of the pharmaceutical sector for 2010, 2011, and 2012 were 29 times, 22 times, and 18 times respectively. The absolute valuation has fallen below the historical average, approaching the 20-times valuation level during the 2008 low point, and the low valuation provides support for the rebound of the pharmaceutical industry. Related thematic articles: Combined nasal endoscopy and maxillary bone horizontal osteotomy approach (Le Fort I) for resection of nasopharyngeal angiofibroma involving the pterygopalatine fossa - Chengdu Gospel.